arrow
P

Piotr Futyma

st josephs heart rhythm centre
H指数:19
被引数:1,003

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Essential antiarrhythmic drug accessibility worldwide: a multi-survey study and comprehensive evaluation of access and supply challenges

全球抗心律失常药物的可及性:一项多调查研究和获取与供应挑战的综合评估

2026-09-020
OAAI
Primary prevention implantable cardioverter-defibrillator therapy in non-ischaemic heart failure with reduced left ventricular ejection fraction: a European Heart Rhythm Association survey

非缺血性射血分数降低的心力衰竭患者的一级预防植入式心律转复除颤器治疗:欧洲心律协会调查

2026-01-010
OA
Atypical atrial flutter ablation: clinical practice on patient selection, mapping, ablation strategies, and procedural endpoints-results from a European Heart Rhythm Association survey

非典型心房扑动消融:患者选择、标测、消融策略及手术终点方面的临床实践——欧洲心律协会调查结果

2025-12-010
PRE
Peri-procedure and Mid-Long Term Effects of Pulsed Field Ablation vs. Thermal Ablation (Cryo- or Radiofrequency) on Autonomic Nervous System Function in Atrial Fibrillation: A Systematic and Quantitative Pooled-Analysis with Potential Implications for Patient Selection (The PULSE-COLD-HEAT-ANS Collaboration)

围手术期及中期-长期效果:脉冲场消融与热消融(冷冻或射频)对心房颤动自主神经系统功能的影响——一项系统性与定量合并分析,并探讨其对患者选择的潜在影响(PULSE-COLD-HEAT-ANS协作组)

2025-11-010
OAAI
Role of the wearable cardioverter defibrillator in the initial period of sudden cardiac death risk stratification: results of a European Heart Rhythm Association survey

可穿戴式心电转复除颤器在突发性心脏死亡风险分层初始期中的作用:欧洲心律协会调查结果

2025-07-012
OAAI
Effects of sodium-glucose co-transporter inhibitors on individual clinical endpoints and quality of life

钠-葡萄糖共转运蛋白抑制剂对个体临床终点和生活质量的影响

2024-11-200
OAAI